美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Brookfield Real Assets Income Fund Inc.

13.22

+0.11000.84%

成交量：19.47万

成交额：257.65万

市值：7.30亿

市盈率：-8.16

高：13.28

开：13.22

低：13.20

收：13.11

数据加载中...

总览公司新闻公告

Anaptysbio, Inc.盘中异动早盘股价大涨5.32%

Igm Biosciences, Inc.盘中异动股价大跌5.19%

港股异动 | 中国抗体-B(03681)涨超18% 公司撤回舒西利单抗治疗RA上市申请该药具备治疗SLE潜力

【港股异动 | 中国抗体-B(03681.HK)涨超18% 公司撤回舒西利单抗治疗RA上市申请该药具备治疗SLE潜力】

Igm Biosciences, Inc.7月15日成交额为65.15万美元

中国抗体-B(03681)：自愿撤回舒西利单抗在中国用于治疗RA的BLA申请

【中国抗体-B(03681.HK)：自愿撤回舒西利单抗在中国用于治疗RA的BLA申请】智通财经APP讯，中国抗体-B(0

Anaptysbio, Inc.盘中异动大幅上涨5.14%报24.66美元

Anaptysbio, Inc.盘中异动早盘快速拉升5.74%

Igm Biosciences, Inc.盘中异动股价大涨5.56%报1.14美元

田见晖：批次化同步扩繁技术，力破我国母猪繁殖、疫病防控顽疾

Igm Biosciences, Inc.盘中异动临近收盘急速下挫5.74%报1.15美元

Igm Biosciences, Inc.盘中异动大幅拉升5.08%报1.24美元

Igm Biosciences, Inc.盘中异动早盘股价大涨5.17%报1.22美元

Igm Biosciences, Inc.盘中异动下午盘急速跳水5.51%报1.20美元

Igm Biosciences, Inc.盘中异动大幅下挫5.19%报1.28美元

Anaptysbio, Inc.盘中异动大幅下挫5.11%报22.49美元

Igm Biosciences, Inc.盘中异动急速拉升6.45%

Anaptysbio, Inc.盘中异动早盘急速跳水5.22%

Anaptysbio, Inc.盘中异动早盘大幅拉升5.01%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/RA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","market":"US","secType":"STK","nameCN":"Brookfield Real Assets Income Fund Inc.","latestPrice":13.22,"timestamp":1753128000000,"preClose":13.11,"halted":0,"volume":194726,"delay":0,"floatShares":55254696,"shares":55254696,"eps":-1.61933,"marketStatus":"盘前交易","change":0.11,"latestTime":"07-22 05:58:14 EDT","open":13.22,"high":13.28,"low":13.2,"amount":2576526.8053,"amplitude":0.006102,"askPrice":13.4,"askSize":2,"bidPrice":12.9,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-1.61933,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753191000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":13.22,"dividendRate":0.107413,"postHourTrading":{"tag":"盘后","latestPrice":13.24,"preClose":13.22,"latestTime":"19:04 EDT","volume":211,"amount":2792.62,"timestamp":1753139049356},"volumeRatio":0.7181973622232238},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RA\",,,,,undefined,":{"symbol":"RA","floatShares":55254696,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7181973622232238,"shares":55254696,"dividePrice":1.42,"high":13.28,"amplitude":0.006102,"preClose":13.11,"low":13.2,"week52Low":11.87,"pbRate":"--","week52High":13.77,"institutionHeld":0,"latestPrice":13.22,"committee":0.2,"eps":-1.61933,"divideRate":0.107413,"volume":194726,"delay":0,"ttmEps":-1.61933,"open":13.22,"prevYearClose":13.32,"prevWeekClose":13.11,"prevMonthClose":13.37,"prevQuarterClose":13.37,"fiveDayClose":13.39,"twentyDayClose":12.94,"sixtyDayClose":12.78},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553885470","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553885470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553885470?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 22:01","pubTimestamp":1753106494,"startTime":"0","endTime":"0","summary":"北京时间2025年07月21日22时01分，Anaptysbio, Inc.股票出现波动，股价快速上涨5.32%。截至发稿，该股报27.30美元/股，成交量5.7931万股，换手率0.20%，振幅5.63%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Promis Neurosciences Inc.、Sab Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Tnf Pharmaceuticals, Inc.、Sab Biotherapeutics, Inc.、Promis Neurosciences Inc.较为活跃，换手率分别为1449.61%、516.22%、450.99%，振幅较大的相关个股有Sab Biotherapeutics, Inc.、Promis Neurosciences Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为122.18%、95.36%、92.46%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721220134a459c32c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721220134a459c32c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2552124027","title":"Igm Biosciences, Inc.盘中异动 股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552124027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552124027?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 00:29","pubTimestamp":1752683383,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日00时29分，Igm Biosciences, Inc.股票出现波动，股价快速跳水5.19%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071700294395450fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071700294395450fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","BK4077","RA","BK4139","BK4505","IGMS"],"gpt_icon":0},{"id":"2551791119","title":"港股异动 | 中国抗体-B(03681)涨超18% 公司撤回舒西利单抗治疗RA上市申请 该药具备治疗SLE潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2551791119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551791119?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:29","pubTimestamp":1752636596,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国抗体-B涨超18%，截至发稿，17.48%，报2.42港元，成交额5080.39万港元。消息面上，中国抗体宣布，经近期与国家药监局药品审评中心沟通后，本公司已自愿撤回舒西利单抗在中国用于治疗类风湿关节炎的BLA申请。公司对舒西利单抗获批准于中国上市仍具信心，已开始规划舒西利单抗用于治疗系统性红斑狼疮的新临床开发计划。值得注意的是，公司近期宣布，其全球首创新药SM03针对系统性红斑狼疮的临床前研究In-vivo取得突破性结果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1318361.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["RA","SLE","BK1161","BK1574","03681","BK4077"],"gpt_icon":0},{"id":"2551119797","title":"【港股异动 | 中国抗体-B(03681.HK)涨超18% 公司撤回舒西利单抗治疗RA上市申请 该药具备治疗SLE潜力】","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119797","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551119797?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 11:29","pubTimestamp":1752636596,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["03681","BK4077","RA","BK1574","SLE","BK1161"],"gpt_icon":0},{"id":"2551119940","title":"Igm Biosciences, Inc.7月15日成交额为65.15万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119940","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551119940?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 10:49","pubTimestamp":1752634152,"startTime":"0","endTime":"0","summary":"美东时间2025年7月15日，Igm Biosciences, Inc.成交额为65.15万美元，成交额较昨日增加115.36%，当日成交量为48.16万股。Igm Biosciences, Inc.于2025年7月15日跌0.74%，报1.35美元，该股过去5个交易日涨1.5%，年初至今跌77.91%，过去60日涨13.45%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-15|65.15万|115.36%|48.16万|#|2025-07-14|30.25万|13.47%|22.36万|#|2025-07-11|26.66万|-50.19%|19.69万|#|2025-07-10|53.53万|-53.69%|39.48万|#|2025-07-09|115.60万|102.47%|86.19万|IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716104913a6ac5f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716104913a6ac5f03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","IGMS","BK4139","BK4077","RA","BK4505"],"gpt_icon":0},{"id":"2551029079","title":"中国抗体-B(03681)：自愿撤回舒西利单抗在中国用于治疗RA的BLA申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2551029079","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551029079?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 18:04","pubTimestamp":1752487451,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国抗体-B 发布公告，诚如公司日期为2023年4月26日及2023年9月5日的公告所披露，舒西利单抗在中国治疗类风湿关节炎的III期临床研究中达到主要终点，并已向中华人民共和国国家药品监督管理局提交生物制品上市许可申请申请。经近期与国家药监局药品审评中心沟通后，公司已自愿撤回舒西利单抗在中国用于治疗RA的BLA申请。公司对舒西利单抗获批准于中国上市仍具信心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1317429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","03681","BK1161","RA"],"gpt_icon":0},{"id":"2551021269","title":"【中国抗体-B(03681.HK)：自愿撤回舒西利单抗在中国用于治疗RA的BLA申请】智通财经APP讯，中国抗体-B(0","url":"https://stock-news.laohu8.com/highlight/detail?id=2551021269","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551021269?lang=zh_cn&edition=fundamental","pubTime":"2025-07-14 18:04","pubTimestamp":1752487451,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK4134","03681","BK1574","RA","BLA.AU","III"],"gpt_icon":0},{"id":"2550527828","title":"Anaptysbio, Inc.盘中异动 大幅上涨5.14%报24.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550527828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550527828?lang=zh_cn&edition=fundamental","pubTime":"2025-07-09 01:51","pubTimestamp":1751997083,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日01时51分，Anaptysbio, Inc.股票出现波动，股价大幅拉升5.14%。截至发稿，该股报24.66美元/股，成交量55.0414万股，换手率1.87%，振幅6.10%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Zyversa Therapeutics, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Rallybio Corporation涨幅较大，Zyversa Therapeutics, Inc.、Moleculin Biotech, Inc.、Rallybio Corporation较为活跃，换手率分别为4003.92%、621.08%、341.90%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为146.75%、73.81%、70.97%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709015124953b1f95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709015124953b1f95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2548813265","title":"Anaptysbio, Inc.盘中异动 早盘快速拉升5.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548813265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548813265?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 22:46","pubTimestamp":1751467579,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时46分，Anaptysbio, Inc.股票出现波动，股价急速上涨5.74%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Nutriband Inc C/Wts 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Windtree Therapeutics, Inc.、Lixte Biotechnology Holdings, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为1866.19%、601.74%、397.11%，振幅较大的相关个股有Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lixte Biotechnology Holdings, Inc.，振幅分别为1145.92%、393.59%、96.61%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222461995340ed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222461995340ed8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2547409098","title":"Igm Biosciences, Inc.盘中异动 股价大涨5.56%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547409098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547409098?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 21:44","pubTimestamp":1751291047,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时44分，Igm Biosciences, Inc.股票出现波动，股价大幅拉升5.56%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2258.52%、134.48%、75.37%，振幅较大的相关个股有Artelo Biosciences, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 、Eyenovia, Inc.，振幅分别为79.51%、34.23%、26.93%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021440795315457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021440795315457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RA","SLE","BK4077","BK4139","IGMS"],"gpt_icon":0},{"id":"2546772856","title":"田见晖：批次化同步扩繁技术，力破我国母猪繁殖、疫病防控顽疾","url":"https://stock-news.laohu8.com/highlight/detail?id=2546772856","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546772856?lang=zh_cn&edition=fundamental","pubTime":"2025-06-28 17:02","pubTimestamp":1751101320,"startTime":"0","endTime":"0","summary":"目前，这项技术已在牧原、温氏、新希望等国内65%以上的养猪企业推广应用，有效解决了生猪养殖中繁殖生产效率低、疫病防控两大痛点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-06-28/doc-infcrmwe2690308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PSY","RA"],"gpt_icon":0},{"id":"2546372995","title":"Igm Biosciences, Inc.盘中异动 临近收盘急速下挫5.74%报1.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546372995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546372995?lang=zh_cn&edition=fundamental","pubTime":"2025-06-28 03:50","pubTimestamp":1751053847,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Igm Biosciences, Inc.股票出现波动，股价大幅下挫5.74%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Eyenovia, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、天境生物涨幅较大，Inmune Bio Inc.、Hcw Biologics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为245.65%、168.88%、137.58%，振幅较大的相关个股有Inmune Bio Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation，振幅分别为105.57%、74.75%、64.91%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280350479791c250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506280350479791c250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","IGMS","BK4505","BK4077","BK4139","SLE"],"gpt_icon":0},{"id":"2546235482","title":"Igm Biosciences, Inc.盘中异动 大幅拉升5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546235482","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546235482?lang=zh_cn&edition=fundamental","pubTime":"2025-06-26 03:15","pubTimestamp":1750878901,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日03时15分，Igm Biosciences, Inc.股票出现异动，股价急速上涨5.08%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626031501a4bdd1b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626031501a4bdd1b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","RA","BK4139","IGMS","BK4077","BK4505"],"gpt_icon":0},{"id":"2545549231","title":"Igm Biosciences, Inc.盘中异动 早盘股价大涨5.17%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545549231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545549231?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 23:16","pubTimestamp":1750778215,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时16分，Igm Biosciences, Inc.股票出现异动，股价快速上涨5.17%。截至发稿，该股报1.22美元/股，成交量1.9881万股，换手率0.03%，振幅6.43%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231655978d0661&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624231655978d0661&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","IGMS","BK4077","BK4139","RA","SLE"],"gpt_icon":0},{"id":"2543544857","title":"Igm Biosciences, Inc.盘中异动 下午盘急速跳水5.51%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543544857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543544857?lang=zh_cn&edition=fundamental","pubTime":"2025-06-13 02:39","pubTimestamp":1749753565,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日02时39分，Igm Biosciences, Inc.股票出现异动，股价急速下跌5.51%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613023925a705d573&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613023925a705d573&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","BK4077","SLE","IGMS","BK4505"],"gpt_icon":0},{"id":"2542536090","title":"Igm Biosciences, Inc.盘中异动 大幅下挫5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542536090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542536090?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 00:18","pubTimestamp":1749658705,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日00时18分，Igm Biosciences, Inc.股票出现异动，股价急速跳水5.19%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Kazia Therapeutics Limited、Vaxart, Inc. - Common Stock、Jupiter Neurosciences, Inc.涨幅较大，Nucana Plc、Kazia Therapeutics Limited、Windtree Therapeutics, Inc.较为活跃，换手率分别为10481.84%、3068.46%、190.35%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Kazia Therapeutics Limited，振幅分别为88.67%、84.50%、79.16%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612001825a4a3bfba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612001825a4a3bfba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","BK4505","BK4077","BK4139","RA","IGMS"],"gpt_icon":0},{"id":"2542098339","title":"Anaptysbio, Inc.盘中异动 大幅下挫5.11%报22.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542098339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542098339?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 00:56","pubTimestamp":1749488213,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日00时56分，Anaptysbio, Inc.股票出现波动，股价急速下跌5.11%。截至发稿，该股报22.49美元/股，成交量19.186万股，换手率0.65%，振幅7.93%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.涨幅较大，Nucana Plc、Synaptogenix, Inc.、Klotho Neurosciences, Inc.较为活跃，换手率分别为8971.63%、2970.41%、2744.66%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Citius Pharmaceuticals, Inc.，振幅分别为582.93%、465.28%、175.09%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610005654a4a0af4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610005654a4a0af4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2541367869","title":"Igm Biosciences, Inc.盘中异动 急速拉升6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541367869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541367869?lang=zh_cn&edition=fundamental","pubTime":"2025-06-06 22:52","pubTimestamp":1749221563,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日22时52分，Igm Biosciences, Inc.股票出现异动，股价大幅拉升6.45%。Igm Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Klotho Neurosciences, Inc.、Eyenovia, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Nucana Plc、Eyenovia, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为2291.01%、743.77%、84.89%，振幅较大的相关个股有Eyenovia, Inc.、Klotho Neurosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为41.40%、35.57%、34.76%。Igm Biosciences, Inc.公司简介：IGM Biosciences Inc是一家生物技术公司，致力于开发IgM抗体疗法，用于治疗癌症、传染病、自身免疫性和炎症性疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606225244a49d0f08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606225244a49d0f08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SLE","RA","BK4077","BK4139","IGMS","BK4505"],"gpt_icon":0},{"id":"2541607668","title":"Anaptysbio, Inc.盘中异动 早盘急速跳水5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541607668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541607668?lang=zh_cn&edition=fundamental","pubTime":"2025-06-05 21:43","pubTimestamp":1749131025,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时43分，Anaptysbio, Inc.股票出现异动，股价急速跳水5.22%。截至发稿，该股报20.16美元/股，成交量2.1648万股，换手率0.07%，振幅4.28%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Liminatus Pharma Inc C/Wts 30/04/2030 、Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Nucana Plc、Silo Pharma, Inc.较为活跃，换手率分别为1271.23%、288.71%、156.72%，振幅较大的相关个股有Scinai Immunotherapeutics Ltd、Liminatus Pharma, Inc.、Liminatus Pharma Inc C/Wts 30/04/2030 ，振幅分别为59.92%、45.48%、39.21%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214346a49b82c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605214346a49b82c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2540080257","title":"Anaptysbio, Inc.盘中异动 早盘大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540080257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540080257?lang=zh_cn&edition=fundamental","pubTime":"2025-06-03 22:47","pubTimestamp":1748962045,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日22时47分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.01%。截至发稿，该股报22.96美元/股，成交量8.8784万股，换手率0.30%，振幅5.67%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Biomea Fusion, Inc.、Traws Pharma, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、Traws Pharma, Inc.、Nucana Plc较为活跃，换手率分别为3876.26%、1000.07%、846.41%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Biomea Fusion, Inc.、Renovaro Inc.，振幅分别为79.71%、69.03%、57.30%。Anaptysbio, Inc.公司简介：AnaptysBio Inc是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060322472697700776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060322472697700776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RA\",params:#limit:5,,,undefined,":[{"date":"2025-09-11","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-11","defaultRemindTime":1757597400000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-11","currency":"USD","dateTimestamp":1757563200000,"payDate":"2025-09-25"},{"date":"2025-08-07","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-07","defaultRemindTime":1754573400000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-21","payableDate":"2025-08-07","currency":"USD","dateTimestamp":1754539200000,"payDate":"2025-08-21"},{"date":"2025-07-10","symbol":"RA","amount":0.118,"announcedDate":"2025-06-27","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-10","defaultRemindTime":1752154200000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-24","payableDate":"2025-07-10","currency":"USD","dateTimestamp":1752120000000,"payDate":"2025-07-24"},{"date":"2025-06-12","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-12","defaultRemindTime":1749735000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-26","payableDate":"2025-06-12","currency":"USD","dateTimestamp":1749700800000,"payDate":"2025-06-26"},{"date":"2025-05-08","symbol":"RA","amount":0.118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-08","defaultRemindTime":1746711000000,"name":"Brookfield Real Assets Income Fund Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-08","currency":"USD","dateTimestamp":1746676800000,"payDate":"2025-05-22"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RA\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-13","recordDate":"2016-12-15","paymentDate":"2016-12-22","value":0.199,"currency":"USD"},{"executeDate":"2017-03-14","recordDate":"2017-03-16","paymentDate":"2017-03-23","value":0.199,"currency":"USD"},{"executeDate":"2017-04-18","recordDate":"2017-04-20","paymentDate":"2017-04-27","value":0.199,"currency":"USD"},{"executeDate":"2017-05-16","recordDate":"2017-05-18","paymentDate":"2017-05-25","value":0.199,"currency":"USD"},{"executeDate":"2017-06-13","recordDate":"2017-06-15","paymentDate":"2017-06-22","value":0.199,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RA\",market:\"US\",delay:false,,,undefined,":{}}}